KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Retained Earnings: 2015-2024

Historic Retained Earnings for BeOne Medicines (ONC) over the last 10 years, with Dec 2024 value amounting to -$8.6 billion.

  • BeOne Medicines' Retained Earnings rose 0.81% to -$8.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 billion, marking a year-over-year increase of 0.81%. This contributed to the annual value of -$8.6 billion for FY2024, which is 8.10% down from last year.
  • Latest data reveals that BeOne Medicines reported Retained Earnings of -$8.6 billion as of FY2024, which was down 8.10% from -$8.0 billion recorded in FY2023.
  • BeOne Medicines' 5-year Retained Earnings high stood at -$3.6 billion for FY2020, and its period low was -$8.6 billion during FY2024.
  • In the last 3 years, BeOne Medicines' Retained Earnings had a median value of -$8.0 billion in 2023 and averaged -$7.9 billion.
  • Data for BeOne Medicines' Retained Earnings shows a maximum YoY crashed of 81.65% (in 2020) over the last 5 years.
  • BeOne Medicines' Retained Earnings (Yearly) stood at -$3.6 billion in 2020, then tumbled by 42.89% to -$5.1 billion in 2021, then crashed by 39.47% to -$7.1 billion in 2022, then fell by 12.45% to -$8.0 billion in 2023, then decreased by 8.10% to -$8.6 billion in 2024.